军事知识服务平台
银葶清肺口服液防治小儿呼吸道合胞病毒肺炎理论探析与作用机制假说
Theoretical analysis and mechanistic hypothesis of Yinting Qingfei Oral Liquid in the prevention and treatment of pediatric respiratory syncytial virus pneumonia
摘要 小儿呼吸道合胞病毒(RSV)肺炎以痰热闭肺证为常见证型之一,银葶清肺口服液为我院院内制剂,能宣肺清热、化痰平喘,长年用于此病疗效显著,但其作用机制尚未得到系统理论阐释.为保证理论推演的数据客观性,本文文献检索覆盖 PubMed、中国知网、万方等数据库,以"RSV""呼吸道合胞病毒"及药物名称为检索词,优先纳入实验性研究.本文梳理 RSV 致病机制与痰热闭肺证的病机关键点;继而将方中药物按功能模块整合为"病毒生命周期干预""核心抗炎通路调控网络""对症与组织保护作用"三大层面,并在此基础上首次提出"分阶段分工协作"的复方协同作用假说;探讨未来研究需验证的关键科学问题.旨在为银葶清肺口服液抗 RSV 的机制研究提供可检验的假说框架.
Abstract:
Pediatric pneumonia caused by respiratory syncytial virus(RSV)frequently presents as the syndrome of phlegm-heat obstructing the lung.Yinting Qingfei Oral Liquid,known for dispersing lung heat,resolving phlegm,and calming panting,has demonstrated clinical efficacy against this condition,yet its mechanism of action lacks systematic theoretical interpretation.To ensure the objectivity of the theoretical derivation,the literature review was conducted systematically across databases including PubMed,CNKI,and Wanfang Data,using search terms such as"RSV","respiratory syncytial virus",and the names of each herbal component,with priority given to experimental studies.This review first outlines the key aspects of RSV pathogenesis and the TCM syndrome characteristics.Then,for the first time,it integrates the herbal components into three functional modules:"Viral life cycle intervention","core anti-inflammatory regulatory network",and"symptom relief and tissue protection".Based on this integration,it proposes a"phase-specific division of labor"synergistic action hypothesis.Finally,it identifies key scientific questions for future validation.This paper aims to provide theoretical support for the clinical application of Yinting Qingfei Oral Liquid and offer a testable hypothesis framework for mechanistic research on TCM formulas against RSV.
刊 名 四川中医
年,卷(期): 2026, 44(10)
分类号: R285
机标分类号: R285.6 R563.1 R725.6
在线出版日期: 2026年11月10日
基金项目: 21PJ01:成都中医药大学附属医院科技发展基金,